Nature.com Publication on EEG Biomarkers for Precision Psychiatry
e are thrilled to announce the publication of our latest research on Nature.com, focusing on EEG biomarkers and their ap …
Brainify.AI CEO, Mariam Khayretdinova, presents latest results at MIT
Mark Your Calendars! 🗓️ Mariam Khayretdinova, the visionary CEO & co-founder of Brainify.AI, is gearing up to unvei …
Brainify.AI Welcomes Dr. Jim Doherty as New Advisory Board Member
Brainify.AI, a pioneering company at the forefront of AI precision psychiatry, today announced the appointment of Dr. Ji …
Brainify.AI CEO to Pitch at HBS Healthcare Alumni Startup Showcase
Brainify.AI is proud to announce CEO Mariam’s participation in the Harvard Business School Healthcare Alumni Association …
Brainify.AI to Spotlight AI-Driven Psychiatry Innovations at Biotech Showcase 2024
Brainify.AI, a frontrunner in the field of precision psychiatry, is set to present its latest advancements at the presti …
Brainify.AI Is Accepted Into Merck Digital Sciences Studio Program
New York City - November 28, 2028
Brainify.AI and Clerkenwell Health Forge New Path in Precision Psychiatry
NEW YORK, November 14, 2023 – Brainify.AI, an innovator in the artificial intelligence (AI) and electroencephalography ( …
Brainify.AI and HIVE BIO Forge Game-Changing Partnership to Catalyze the Future of Precision Psychiatry With Proprietary EEG Biomarkers
NEW YORK, October 31, 2023
Brainify AI Showcases Groundbreaking Solutions at Plug and Play's Healthcare Event
In a landscape where U.S. venture capital firms have invested over $46 billion into healthcare-focused AI startups, Brai …
6th Annual Neuropsychiatric Drug Development Summit Spotlights Brainify.AI's Breakthrough in Precision Neuropsychiatry
The neuropsychiatry landscape is evolving, and the 6th Annual Neuropsychiatric Drug Development Summit aims to encapsula …
